T. Rowe Price Investment Management’s Prelude Therapeutics PRLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-281,583
Closed -$583K 666
2024
Q3
$583K Buy
+281,583
New +$583K ﹤0.01% 606